Benefits of Iron Chelators in the Treatment of Parkinson's Disease
In conclusion, we indicated that overloaded intracellular iron contributes to neurons death via apoptosis and ferroptosis pathways, while DFO, an iron chelator, can inhibit ferroptosis in order to protect the neurons in vitro.PMID:33646533 | DOI:10.1007/s11064-021-03262-9
Source: Neurochemical Research - Category: Neuroscience Authors: Xiaoyan Zeng Hedi An Fei Yu Kai Wang Lanlan Zheng Wei Zhou Yiwen Bao Jie Yang Nan Shen Dongya Huang Source Type: research
More News: Brain | Iron | Mitochondrial Disease | Neurology | Neuroscience | Parkinson's Disease | Pheochromocytoma | Study